Pharmacogenetics-guided CETP inhibition: an open question?
Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt
Standard
Pharmacogenetics-guided CETP inhibition : an open question? / Tybjærg-Hansen, Anne; Nordestgaard, Liv Tybjærg; Christoffersen, Mette.
I: European Heart Journal, Bind 43, Nr. 39, 2022, s. 3957-3959.Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt
Harvard
Tybjærg-Hansen, A, Nordestgaard, LT & Christoffersen, M 2022, 'Pharmacogenetics-guided CETP inhibition: an open question?', European Heart Journal, bind 43, nr. 39, s. 3957-3959. https://doi.org/10.1093/eurheartj/ehac398
APA
Tybjærg-Hansen, A., Nordestgaard, L. T., & Christoffersen, M. (2022). Pharmacogenetics-guided CETP inhibition: an open question? European Heart Journal, 43(39), 3957-3959. https://doi.org/10.1093/eurheartj/ehac398
Vancouver
Tybjærg-Hansen A, Nordestgaard LT, Christoffersen M. Pharmacogenetics-guided CETP inhibition: an open question? European Heart Journal. 2022;43(39):3957-3959. https://doi.org/10.1093/eurheartj/ehac398
Author
Bibtex
@article{ec33117d7d374c1890c027d621c2f306,
title = "Pharmacogenetics-guided CETP inhibition: an open question?",
author = "Anne Tybj{\ae}rg-Hansen and Nordestgaard, {Liv Tybj{\ae}rg} and Mette Christoffersen",
year = "2022",
doi = "10.1093/eurheartj/ehac398",
language = "English",
volume = "43",
pages = "3957--3959",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "39",
}
RIS
TY - JOUR
T1 - Pharmacogenetics-guided CETP inhibition
T2 - an open question?
AU - Tybjærg-Hansen, Anne
AU - Nordestgaard, Liv Tybjærg
AU - Christoffersen, Mette
PY - 2022
Y1 - 2022
U2 - 10.1093/eurheartj/ehac398
DO - 10.1093/eurheartj/ehac398
M3 - Editorial
C2 - 35924304
AN - SCOPUS:85140144656
VL - 43
SP - 3957
EP - 3959
JO - European Heart Journal
JF - European Heart Journal
SN - 0195-668X
IS - 39
ER -
ID: 324000611